InvestorsHub Logo
Followers 0
Posts 312
Boards Moderated 0
Alias Born 04/07/2017

Re: None

Monday, 02/05/2018 10:03:00 AM

Monday, February 05, 2018 10:03:00 AM

Post# of 8112
LAS VEGAS, Feb. 5, 2018/PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has filed a nonprovisional patent application to protect its cannabinoid-containing complex mixtures for the treatment of inflammatory disorders. The new patent application claims the benefit of GB Sciences' provisional patent previously filed on February 1, 2017; plus, additional data describing their mechanism of action and further supporting their claims. Inflammatory disorders, such as arthritis, asthma, eczema, psoriasis, Crohn's disease and Inflammatory Bowel Disease, represent a serious health burden in the US with over$200 billion spent annually. New cannabis-based therapies could significantly help both patients and society.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GBLX News